We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Continued Safety Monitoring of Solanezumab in Alzheimer's Disease (EXPEDITION EXT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01127633
Recruitment Status : Terminated (Solanezumab did not meet the primary endpoint in study H8A-MC-LZAX.)
First Posted : May 21, 2010
Last Update Posted : March 8, 2017
Information provided by (Responsible Party):

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : July 2014
  Study Completion Date : February 2017
  Certification or Request for Extension to Delay Results Submission: September 29, 2014